Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
CROPS, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 58%, Oct-Dec Ordinary Profit Increases by 75%
9428 CROPS CORPORATION 【J-GAAP】
Earnings ReportCROPS CORPORATION <9428> [TSE Std] announced its financial results after the market closed on February 12th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2026 (April to December) expanded 2.65 billion yen, an increase 57.5% compared to the same period last year. Progress toward the full-year plan of 3.41 billion yen was 77.7%, also surpassing the five-year average of 75.4%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to decrease 20.2% from the same period last year to 0.75 billion yen.
In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit increased 74.9% from the same period last year, reaching 1.19 billion yen. The operating profit margin improved from 4.8% in the same period last year to 6.0%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Dec, 2023 | 40,110 | 1,654 | 1,882 | 1,011 | 106.9 | 81.3 | Feb 5, 2024 | J-GAAP |
| Apr - Dec, 2024 | 45,262 | 1,562 | 1,683 | 381 | 40.3 | 63.9 | Feb 14, 2025 | J-GAAP |
| Apr - Dec, 2025 | 48,645 | 2,456 | 2,651 | 641 | 67.8 | 77.7 | Feb 12, 2026 | J-GAAP |
| YoY | +7.5% | +57.2% | +57.5% | +68.2% | +68.2% |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2024 | 32,357 | 1,624 | 1,632 | 883 | 93.4 | 20 | May 13, 2025 | J-GAAP |
| Oct - Mar, 2025 Guidance | 35,890 | 1,782 | 1,950 | 1,197 | 126.6 | 25 | Nov 13, 2025 | J-GAAP |
| YoY | +10.9% | +9.7% | +19.5% | +35.6% | +35.5% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 54,487 | 2,127 | 2,316 | 1,206 | 127.5 | 20 | May 14, 2024 | J-GAAP |
| Mar, 2025 | 61,568 | 2,416 | 2,634 | 991 | 104.8 | 20 | May 13, 2025 | J-GAAP |
| Mar, 2026 Guidance | 67,121 | 3,201 | 3,410 | 1,177 | 124.5 | 25 | Nov 13, 2025 | J-GAAP |
| YoY | +9.0% | +32.5% | +29.5% | +18.8% | +18.8% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Dec, 2024 | 16,051 | 770 | 681 | 273 | 28.9 | 4.8 | Feb 14, 2025 | J-GAAP |
| Jan - Mar, 2025 | 16,306 | 854 | 951 | 610 | 64.5 | 5.2 | May 13, 2025 | J-GAAP |
| Apr - Jun, 2025 | 15,717 | 832 | 836 | 299 | 31.7 | 5.3 | Aug 8, 2025 | J-GAAP |
| Jul - Sep, 2025 | 15,514 | 587 | 624 | -319 | -34.0 | 3.8 | Nov 13, 2025 | J-GAAP |
| Oct - Dec, 2025 | 17,414 | 1,037 | 1,191 | 661 | 69.9 | 6.0 | Feb 12, 2026 | J-GAAP |
| YoY | +8.5% | +34.7% | +74.9% | +142.1% | +142.1% |
Related Articles
Immuno-Biological Lab, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 83%, Oct-Dec Ordinary Profit Increases by 34%
Citizen Watch, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 16%
Reskill Corp, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 23%, Raises Record High Profit Forecast
NHK SPRING, Oct-Dec (3Q) Ordinary Profit Increases by 33%
AltPlus, Oct-Dec (1Q) Ordinary Profit Loss Narrows
EIDAI KAKO, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 45%, Dividend Revised Upward by 10 Yen
KYOWANISSEI, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 87%, Oct-Dec Ordinary Profit Increases by 39%
T&S Group, Oct-Dec (1Q) Ordinary Profit Increases by 12%
Lion, 9% Decrease in Net Income for The Current Fiscal Year, Dividend Raised by 4 Yen
MarkLines, 11% Increase in Ordinary Profit, Record High for The First Time in Two Years, Dividend Raised by 6 Yen